Literature DB >> 19047341

Telomere biology in cardiovascular disease: the TERC-/- mouse as a model for heart failure and ageing.

Liza S M Wong1, Hisko Oeseburg, Rudolf A de Boer, Wiek H van Gilst, Dirk J van Veldhuisen, Pim van der Harst.   

Abstract

Atherosclerosis and heart failure are major causes of morbidity and mortality in Western countries. Recent studies are suggesting involvement of telomere biology in the development and progression of age-associated conditions, including hypertension, atherosclerosis, and heart failure. Whether any of these reported associations are based on causal relationships remains to be elucidated. The construction of telomerase-deficient (telomerase RNA component, TERC(-/-)) mice might provide a potential instrumental model to study the involvement of telomere biology in cardiovascular disease. Here, we review the current available information from all studies performed in TERC(-/-) mice providing information on the cardiovascular phenotypic characteristics. Although this mouse model has proven its value in the understanding of the role of telomere biology in cancer, stem cell, and basic telomere research, only few studies were specifically designed to answer cardiovascular-related questions. The TERC(-/-) mice provide exciting opportunities to expand our knowledge of telomere biology in cardiovascular disease and the potential identification of novel targets of treatment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19047341     DOI: 10.1093/cvr/cvn337

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  32 in total

1.  The end is nigh.

Authors:  Friedrich C Luft
Journal:  J Mol Med (Berl)       Date:  2010-08       Impact factor: 4.599

Review 2.  Friend or foe? Telomerase as a pharmacological target in cancer and cardiovascular disease.

Authors:  Karima Ait-Aissa; Johnathan D Ebben; Andrew O Kadlec; Andreas M Beyer
Journal:  Pharmacol Res       Date:  2016-07-06       Impact factor: 7.658

Review 3.  Targeting Age-Related Pathways in Heart Failure.

Authors:  Haobo Li; Margaret H Hastings; James Rhee; Lena E Trager; Jason D Roh; Anthony Rosenzweig
Journal:  Circ Res       Date:  2020-02-13       Impact factor: 17.367

4.  An intricate dance: Life experience, multisystem resiliency, and rate of telomere decline throughout the lifespan.

Authors:  Eli Puterman; Elissa Epel
Journal:  Soc Personal Psychol Compass       Date:  2012-11-05

Review 5.  Noncoding RNAs Controlling Telomere Homeostasis in Senescence and Aging.

Authors:  Martina Rossi; Myriam Gorospe
Journal:  Trends Mol Med       Date:  2020-02-28       Impact factor: 11.951

6.  Nuclear factor {kappa}B-mediated transactivation of telomerase prevents intimal smooth muscle cell from replicative senescence during vascular repair.

Authors:  De-xiu Bu; Maria E Johansson; Jingyi Ren; Da-wei Xu; F Brad Johnson; Kristina Edfeldt; Zhong-qun Yan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-09-23       Impact factor: 8.311

Review 7.  Telomere biology in healthy aging and disease.

Authors:  Hisko Oeseburg; Rudolf A de Boer; Wiek H van Gilst; Pim van der Harst
Journal:  Pflugers Arch       Date:  2009-09-10       Impact factor: 3.657

Review 8.  The roles of senescence and telomere shortening in cardiovascular disease.

Authors:  Frej Fyhrquist; Outi Saijonmaa; Timo Strandberg
Journal:  Nat Rev Cardiol       Date:  2013-03-12       Impact factor: 32.419

Review 9.  Insulin signaling and life span.

Authors:  Angelo Avogaro; Saula Vigili de Kreutzenberg; Gian Paolo Fadini
Journal:  Pflugers Arch       Date:  2009-09-13       Impact factor: 3.657

Review 10.  Telomeres and disease.

Authors:  Peter M Lansdorp
Journal:  EMBO J       Date:  2009-07-23       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.